Lords Mark Industries Ltd

Desk›Diversified› Lords Mark Industries Ltd

Lords Mark Industries Ltd

BSE 501261 · NSE LORDSMARK · ISIN INE567L01025 · Group XT · Active

Diversified › Diversified › Diversified › Diversified

₹80.35

-0.66%

BSE close, 28 August 2026

Market cap

₹3,427.91 cr

42.7 cr shares · Micro cap

Free float

₹1,748.06 cr

as published

P/E · P/B

40.4× · 892.78×

EPS ₹1.99 · BV ₹0.09

FY25-26 rev / PAT

601.71 / 52.76

₹ cr, as filed

Filings, window

12 selected · 36%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

Against 52-week high	-88.0%
Against 52-week low	+33.9%
Day change	-0.66%
Size band	Micro cap
Index membership	None

Valuation as published by BSE

Earnings per share	₹1.99
Price / earnings	40.38×
Price / book	892.78×
Book value — derived, price ÷ P/B	₹0.09
Return on equity	2,124.05%
Operating margin	18.21%
Net margin	11.47%

Consistency check

P/B ÷ P/E, which must equal ROE: 2,210.95%
ROE as published: 2,124.05%

Results ₹ crore, as filed

Jun-26 · Q

Mar-26 · Q

FY25-26

RevenueNet profit one scale across all three periods, ₹ crore

Period	Revenue ₹cr	Net profit ₹cr	EPS ₹	OPM	NPM
Jun-26 · Q	280.36	32.16	0.75	18.21%	11.47%
Mar-26 · Q	441.98	41.22	0.97	14.03%	9.33%
FY25-26	601.71	52.76	1.24	14.59%	8.77%

Quarter on quarter

Revenue, quarter on quarter: -36.6%
Net profit, quarter on quarter: -22.0%
Operating margin, quarter on quarter: +418 bps

Disclosure profile 33 filings in the window

Shaded is the middle half of the sector, 10 to 18 filings. Measured against the 16 Diversified companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.

Tag	Filings
Selected
Investor Presentation	5
Acquisition	2
Board Outcome	2
Credit Rating	1
KMP	1
Results	1
Selected sub-total	12
Procedural
General	14
SAST	3
AGM / EGM	2
Compliance Certificate	1
Trading Window	1
Procedural sub-total	21
Total	33

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group XT, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 98 trading days

33 filings · 12 selected · busiest 2026-08-13

Filing rhythm · the twelve most recent

2026-09-292026-10-14

SelectedProcedural

Filings

33 in the window · 24 earlier on record

14 October 2026 · 18:21 IST

KMP

Appointment of Company Secretary and Compliance Officer

Appointment of CS

Company Update / Appointment of Company Secretary / Compliance Officer View filing →
12 October 2026 · 17:59 IST

Acquisition

Updates on Acquisition

Acquisition Intimation

Company Update / Acquisition View filing →
12 October 2026 · 08:41 IST

Acquisition

Acquisition

Intimation for acquisition of Radiotone.

Company Update / Acquisition View filing →
6 October 2026 · 17:55 IST

Compliance Certificate

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

September 2026 certificate

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
5 October 2026 · 08:40 IST

General

Intimation Titled -Lord'S Mark Industries Limited Receives MHRA Registration For IVD Portfolio; UK Commercial Sales To Begin December 2026

Update regarding MHRA Registration for IVD portfolio..

Company Update / General View filing →
1 October 2026 · 15:05 IST

General

Re-Investment Of Funds Received From Sale Of 89,98,598 Equity Shares By Promoter Mr. Sachidanand Hariram Upadhyay For Medical Device Unit Expansion Of The Company.

Re-investment of funds received from sale of 89,98,598 Equity shares by Promoter Mr. Sachidanand Hariram Upadhyay for Medical Device Unit Expansion of the company.

Company Update / General View filing →
1 October 2026 · 10:28 IST

SAST

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sachidanant Upadhyay

Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
1 October 2026 · 10:17 IST

SAST

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sachidanand Upadhyay

Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
30 September 2026 · 22:43 IST

General

Intimation Regarding Achievement Of Minimum Public Shareholding (MPS) Of 25% Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Achieved MPS of 25%

Company Update / General View filing →
30 September 2026 · 22:39 IST

AGM / EGM

Shareholder Meeting / Postal Ballot-Scrutinizer's Report

Voting results and Scrutinizer report

AGM/EGM / AGM View filing →
30 September 2026 · 16:11 IST

AGM / EGM

Shareholder Meeting / Postal Ballot-Outcome of AGM

Proceeding of AGM held on 30-09-2026

AGM/EGM / AGM View filing →
29 September 2026 · 16:41 IST

Trading Window

Closure of Trading Window

Trading window closure for September results

Insider Trading / SAST / Closure of Trading Window View filing →
28 September 2026 · 08:33 IST

General

Intimation Titled 'From An Indian Innovation To A Global Renal-Care Opportunity: Lord'S Mark Industries Takes Its AI-Powered Dialysis Ecosystem Closer To International Markets'

AI powered dialysis update

Company Update / General View filing →
24 September 2026 · 08:31 IST

General

Intimation Regarding Confirmation And Proposal Received From Promoter, Mr. Sachidanand Hariram Upadhyay For Re-Investment Of Funds Received From Sale Of Equity Shares Of The Company For Medical Device Unit Expansion.

Intimation U/R 30

Company Update / General View filing →
23 September 2026 · 08:33 IST

General

Intimation Titled 'Technical Committee Approves Final Clinical Trial Stage; Company Targets Regulatory Clearances And Commercial Launch By April 2027'

Intimation under regulation 30 regarding AI - Powered Breast Cancer Screening Technology towards final clinical trials

Company Update / General View filing →
22 September 2026 · 12:51 IST

SAST

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sachidanand Hariram Upadhyay

Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
16 September 2026 · 10:19 IST

General

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Completion Of Phase I Expansion At Silvassa Facility Ahead Of Schedule.

Completion of Phase I expansion at Silvassa Facility

Company Update / General View filing →
15 September 2026 · 18:20 IST

Investor Presentation

Investor Presentation

Highlights of investor's meet

Company Update / Investor Presentation View filing →
10 September 2026 · 20:52 IST

Investor Presentation

Investor Presentation

Audio and Video recording of Investor's meet

Company Update / Investor Presentation View filing →
9 September 2026 · 21:03 IST

General

The Company Has Been Invited To Attend Investor Summit Being Organized By Financial Mindss (A Jaibharti Group Co.)

Investor Meet update

Company Update / General View filing →
24 August 2026 · 09:29 IST

General

Subject: Disclosure Regarding Strategic Collaboration With ARKALL Holdings Limited For Healthcare Expansion Across The Caribbean Region

Strategic Collaboration with ARKALL Holdings Ltd

Company Update / General View filing →
21 August 2026 · 20:04 IST

Investor Presentation

Investor Presentation

Transcript of investor conference call

Company Update / Investor Presentation View filing →
20 August 2026 · 11:09 IST

Investor Presentation

Investor Presentation

Audio Video Recording of investor call

Company Update / Investor Presentation View filing →
18 August 2026 · 13:14 IST

Credit Rating

Credit Rating

Credit Rating revised

Company Update / Credit Rating View filing →
17 August 2026 · 16:34 IST

Investor Presentation

Investor Presentation

Company has been appointed to meet investor summit

Company Update / Investor Presentation View filing →
17 August 2026 · 11:36 IST

General

News Paper Publishment

News Paper Publishment for 30th June 2026 results

Company Update / General View filing →
13 August 2026 · 14:53 IST

General

AGM And Important Dates

AGM and other dates related to AGM and Voting

Company Update / General View filing →
13 August 2026 · 14:50 IST

General

Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Business And Strategic Updates

Business Updates

Company Update / General View filing →
13 August 2026 · 14:44 IST

Results

Financial Results For Quarter Ended On 30Th June 2026

Financial Results and LRR

Result / Financial Results View filing →
13 August 2026 · 14:33 IST

Board Outcome

Board Meeting Outcome for Outcome Of Board Meeting Held On 13 August 2026

Outcome of Board Meeting for quarterly financial results, AGM and appointment of auditors

Board Meeting / Outcome of Board Meeting View filing →
10 August 2026 · 10:03 IST

General

Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Receipt Of Manufacturing License For Biomescan Analytics Platform

Manufacturing license for Biomescan Analytics Platform

Company Update / General View filing →
6 August 2026 · 21:59 IST

Board Outcome

Board Meeting Outcome for Outcome Of Board Meeting Held On August 06, 2026

Outcome attached

Board Meeting / Outcome of Board Meeting View filing →
28 July 2026 · 08:51 IST

General

Clarification To Shareholders And Investors Regarding Trading Status Of Equity Shares Under "Trading Restricted - On Account Of IRP As Per IBC / Recommencement Post IBC - IRP Stage-1"

We would like to inform our shareholders and Investors that your company has represented its case to BSE as the said rule is not applicable to us. The Company has requested the exemption ....

Company Update / General View filing →

RSS feed for Lords Mark Industries Ltd · the 50 most recent filings

Price
Market cap
Sector
Index
PE
Latest quarter revenue
Net profit
Filings in the window